As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar with the ...

Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...

GeoVax was using its HHS contract to develop its next-generation multi-antigen COVID-19 vaccine, which is in Phase IIb ...

Federal investigators are investigating claims suggesting Pfizer delayed announcing test results of its Covid vaccine until after the 2020 presidential election, the Wall Street Journal reported ...

Gavi did not respond immediately to a request for comment. GSK, Clover part ways on COVID-19 vaccine, putting Dynavax in the spotlight In June of 2021, Clover and Gavi signed on to their ...

Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot’s success ... Wednesday GSK’s former head of vaccine development, Philip Dormitzer ...

'Low-sugar' vaccine can provide broad immunity against coronavirus variants Date: March 25, 2025 Source: American Chemical Society Summary: Early animal studies show that a single vaccine could ...